Topic
6 facts from 4 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
1980
In 1980 Genentech and Eli Lilly announced a partnership to produce human insulin using recombinant DNA, the first genetically engineered drug.
“in 1980, Genentech and Eli Lilly, as their partner, changed everything with recombinant DNA and genetic engineering of drugs.”
2005
Eli Lilly's Byetta, derived from Gila monster venom, became the first GLP-1 analog drug in 2005 and needed two injections a day.
“the world's first GLP-1 analog drug finally comes to market for the treatment of type 2 diabetes. Of course, I'm talking about the world-famous, well-known, Bayetta from Eli Lilly.”
2023
Eli Lilly's tirzepatide was approved for diabetes in May 2022 as Mounjaro and for weight loss in November 2023 as Zepbound.
“approved in the U.S. for diabetes treatment in May 2022, and approval just came recently in November 2023 for official FDA-sanctioned weight loss use case under the marketing name ZepBound.”
2025
Chandrasekar named HP and Eli Lilly among large companies testing and building with Stack Internal.
“We have some of the world's largest companies, uh, you know, leveraging and testing and building this with us, you know, HP and Eli Lilly and all these companies”
Undated
Linder says Eli Lilly was recently named the number one most AI-ready company in the world.
“Eli Lilly, which was recently named the number one most AI ready company in the world.”
Undated
Andrew Huberman said Eli Lilly invested hundreds of millions of dollars or more in researching retatrutide, which has gone through phase three trials.
“This is the one that Lilly invested, Eli Lilly invested hundreds of millions of dollars, if not more, into researching, and it's went through phase three.”
Episodes